相关实验视频

Updated: Jul 7, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

对于可操作的N2非小细胞肺癌的辅助疗法的进展:叙述性综述

Lei Liu¹, Yilong Mao¹, Leilei Guo¹

¹Department of Radiation Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

Frontiers in oncology

|February 5, 2025

概括

本研究研究了N2阶段非小细胞肺癌 (NSCLC) 的治疗进展. 它讨论了围绕术后辅助放射治疗 (PORT) 的争议,并探讨了NSCLC患者的最佳治疗策略.

科学领域:

在瘤学瘤学.
胸部外科手术胸部外科手术
辐射瘤学辐射瘤学

背景情况:

非小细胞肺癌 (NSCLC) 仍然是癌症发病率的主要原因.
阶段N2 NSCLC表现出显著的患者生存异质性,需要量身定制的治疗方法.
目前的治疗模式包括新辅助疗法,手术,化疗,放射治疗,向治疗和免疫治疗.

研究的目的:

分析当前对可手术的N2阶段非小细胞肺癌的治疗进展.
批判性地评估围绕 pN2 NSCLC 的术后辅助放射治疗 (PORT) 的争议.
探索N2阶段NSCLC的最佳和适应性治疗策略.

主要方法:

对可操作阶段N2 NSCLC的当前治疗选择的审查.
对术后辅助放射治疗 (PORT) 临床争议的分析.
讨论新兴的辅助向和免疫疗法选择以及预测标记.

主要成果:

由于异质性,N2期NSCLC存在显著的生存差异.
在pN2 NSCLC中经常使用PORT仍然是临床辩论的主题.
辅助向和免疫疗法为预后提供了有希望的新途径.

结论:

优化N2期NSCLC的治疗需要仔细考虑个体患者的因素和新兴疗法.
需要进一步的研究来澄清PORT的作用,并整合新的辅助治疗.
开发由生物标志物指导的适应性治疗策略对于改善pN2 NSCLC的结果至关重要.

关键词:

非小细胞肺癌的肺癌.手术后的免疫疗法在术后进行放射治疗.手术后的有针对性的治疗.阶段 N2 阶段 N2

更多相关视频

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.